Early assessment of treatment response is crucial in patients with soft-tissue sarcoma. A prospective study has examined whether changes in tumor 18 F-fluorodeoxyglucose (FDG) uptake could predict ...

The findings, published in The Lancet, establish pembrolizumab as a new option for patients with this disease. "Soft tissue sarcoma is a rare and complex disease with over 50 different subtypes ...

In rare cases, they invade vital organs and lead to severe problems, including death. Desmoid tumors are related to a group of cancers called soft tissue sarcoma and are treated by cancer doctors. In ...

Efti in combination with pembrolizumab and radiotherapy demonstrates significant efficacy in the neoadjuvant setting in patients with soft tissue sarcoma Over three-fold increase in tumour ...

A new study has shown that adding a drug called pembrolizumab to standard treatments can improve survival for people with ...

Patients with bone and soft tissue sarcomas are treated in the Baylor St. Luke's Medical Center Dan L Duncan Comprehensive Cancer Center by a multidisciplinary team of cancer experts. Orthopedic ...

Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the limb significantly improved disease-free survival, according to the ...

We conduct clinical trials and translational studies into numerous types of sarcoma, such as soft tissue sarcomas. The Sarcoma Clinical Trials Team collaborates with international research groups to ...

Dosing marks a milestone for first engineered cell therapy approved in the U.S. for a solid tumor cancer, synovial sarcoma ...

Researchers from KU Leuven presented novel urokinase plasminogen activator receptor-associated protein (uPARAP)-targeted ...

Sarcoma UK expresses profound sadness at the passing of James McMahon, the former NME journalist and Editor of Kerrang!

The FDA has given accelerated approval to a groundbreaking T cell-based therapy from Adaptimmune for synovial sarcoma, becoming the first new treatment for the rare soft tissue cancer in more than ...